According to Kymera Therapeutics's latest financial reports the company's current earnings are A$87.56 Million. In 2023 the company made an earning of -A$0.24 Billion, an increase over its 2022 earnings that were of -A$0.25 Billion. The earnings displayed on this page is the company's Pretax Income.
Year | Earnings | Change |
---|---|---|
2024 (TTM) | -A$0.25 Billion | 7.71% |
2023 | -A$0.24 Billion | -5.09% |
2022 | -A$0.25 Billion | 54.56% |
2021 | -A$0.16 Billion | 119.98% |
2020 | -A$71.47 Million |